Kolexia
Bossi Alberto
Oncologie radiothérapie
Gustave-Roussy
Villejuif, France
274 Activités
1.5 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Récidive tumorale locale Carcinomes Métastase tumorale Adénocarcinome Néphrocarcinome COVID-19 Tumeurs prostatiques résistantes à la castration Tumeurs de la vessie urinaire

Industries

Janssen
26 collaboration(s)
Dernière en 2023
Ipsen
14 collaboration(s)
Dernière en 2023
Astellas
13 collaboration(s)
Dernière en 2023
Accord Healthcare
8 collaboration(s)
Dernière en 2023

Dernières activités

Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
JAMA oncology   07 mars 2024
PEACE1: A Prospective Randomised Phase III Study Of Androgen Deprivation Therapy With Or Without Docetaxel With Or Without Local Radiotherapy With Or Without Abiraterone Acetate And Prednisone In Patients With Metastatic Hormone-Naïve Prostate Cancer
Essai Clinique (Ipsen)   07 novembre 2023
Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
European urology   11 octobre 2023
Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer.
Cancers   05 octobre 2023
ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy.
Clinical and translational radiation oncology   23 septembre 2023
PEACE-1 trial results with Dr. Alberto Bossi
Youtube @ European Association of Urology   01 juillet 2023
How To Manage T3b Prostate Cancer in the Contemporary Era: Referee Position.
European urology open science   29 mai 2023
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer.
Clinical and translational radiation oncology   09 mai 2023
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer.
Clinical genitourinary cancer   24 mars 2023
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.
European journal of cancer (Oxford, England : 1990)   03 mars 2023